A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine
Condition(s):Human Papillomavirus InfectionLast Updated:January 23, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Human Papillomavirus InfectionLast Updated:January 23, 2024Active, not recruiting
Condition(s):Human Papillomavirus Vaccine; Chronic ConditionLast Updated:February 2, 2024Recruiting
Condition(s):Human Papillomavirus InfectionLast Updated:August 17, 2010Completed
Condition(s):Human Papilloma Virus; Atopic Asthma; Atopic DisordersLast Updated:May 26, 2020Completed
Condition(s):Cervical CancerLast Updated:October 3, 2022Completed
Condition(s):Human Papillomavirus InfectionLast Updated:January 6, 2017Completed
Condition(s):Human Papillomavirus-Related CarcinomaLast Updated:March 5, 2024Active, not recruiting
Condition(s):Human Papillomavirus-Related CarcinomaLast Updated:November 2, 2023Completed
Condition(s):HPV; HIVLast Updated:January 19, 2012Unknown status
Condition(s):Human Papillomavirus Infection; Human Papillomavirus-Related Cervical CarcinomaLast Updated:October 6, 2023Enrolling by invitation
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.